Protocol Ledger

Academic / Institutional Sponsor · Consolidated Sponsor Hub

Assistance Publique - Hôpitaux de Paris: Clinical Trials & FDA Approval Profile

Assistance Publique - Hôpitaux de Paris (Global / Institutional) sponsors 379 reconciled interventional Phase II and Phase III ClinicalTrials.gov studies (2018 to 2026), including 195 active protocols (103 recruiting now), 88 completed protocols, and 0 all-time original FDA Drugs@FDA NDA and BLA approvals.

Track in Studio / Generate Client Brief ->
Early-Stop Rate vs National (13.8%)7.4%
Median Closed Enrollment vs National (145 pts)59 participants

Verified Sponsor Execution & Regulatory Ledger

Reconciled ClinicalTrials.gov v2 & Drugs@FDA Metrics for Assistance Publique - Hôpitaux de Paris
Sponsor MetricVerified Count / Rate
Phase II & III Protocols (2018 to 2026)379
Active Pipeline (Recruiting Now)195 (103)
Completed vs Stopped Early88 / 28 (7.4%)
Median Closed Actual Enrollment59 participants
Physical Hospital Site Disclosure100.0% named hospitals
FDA Drugs@FDA Original NDA/BLA Approvals0 (0 since 2018)

Top Partner U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Partnered With Assistance Publique - Hôpitaux de Paris
Hospital Research SiteLocationShared Protocols
Hôpital CochinParis, Paris9
CHU AmiensAmiens8

Explore interactive annual charts and M&A subsidiary rollups in the Assistance Publique - Hôpitaux de Paris Interactive Dossier, benchmark peers in Rare Genetic, Women's Health, and Other, or review the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI